Walvax Biotechnology Co., Ltd.

Walvax Biotechnology Co., Ltd.verified

300142.SZ

Price:

$11.3

Market Cap:

$18.07B

Walvax Biotechnology Co., Ltd., a biological pharmaceutical company, researches and develops, produces, and sells bio-medicine products in China. The company offers biomedicines, such as vaccines, blood products, and others. It provides Group A, C meningococcal polysaccharide conjugate vaccine for infants below or equal to 2 years preventing diseases, such as cerebrospinal meningitis and septicemia; Group A and C meningococcal polysaccharide vaccine for in adults and children over the age of 2 years and adults to prevent disease caused by the bacterium Neisseria meningitidis group A or group C; and Group ACYW135 meningococcal polysaccharide vaccine for children above 2 years old to prevent e...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2010-11-12

Stock Exchange

SHZ

Ticker

300142.SZ

The Enterprise Value as of December 2025 (TTM) for Walvax Biotechnology Co., Ltd. (300142.SZ) is 16.66B

According to Walvax Biotechnology Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 16.66B. This represents a change of 5.84% compared to the average of 15.74B of the last 4 quarters.

Walvax Biotechnology Co., Ltd. (300142.SZ) Historical Enterprise Value (quarterly & annually)

How has 300142.SZ Enterprise Value performed in the past?

The mean historical Enterprise Value of Walvax Biotechnology Co., Ltd. over the last ten years is 39.04B. The current 16.66B Enterprise Value has changed 4.17% with respect to the historical average. Over the past ten years (40 quarters), 300142.SZ's Enterprise Value was at its highest in in the September 2021 quarter at 95.86B. The Enterprise Value was at its lowest in in the March 2025 quarter at 14.31B.

Quarterly (TTM)
Annual

Average

39.04B

Median

30.18B

Minimum

14.73B

Maximum

86.87B

Walvax Biotechnology Co., Ltd. (300142.SZ) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Walvax Biotechnology Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 83.37%

Maximum Annual Enterprise Value = 86.87B

Minimum Annual Increase = -52.04%

Minimum Annual Enterprise Value = 14.73B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202416.00B-52.04%
202333.36B-45.26%
202260.94B-29.84%
202186.87B50.55%
202057.70B21.43%
201947.52B76.63%
201826.90B-0.40%
201727.01B83.37%
201614.73B-24.07%
201519.40B-36.19%

Walvax Biotechnology Co., Ltd. (300142.SZ) Average Enterprise Value

How has 300142.SZ Enterprise Value performed in the past?

The current Enterprise Value of Walvax Biotechnology Co., Ltd. (300142.SZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

36.77B

5-year avg

50.97B

10-year avg

39.04B

Walvax Biotechnology Co., Ltd. (300142.SZ) Enterprise Value vs. Peers

How is 300142.SZ’s Enterprise Value compared to its peers?

Walvax Biotechnology Co., Ltd.’s Enterprise Value is less than Shenzhen Kangtai Biological Products Co., Ltd. (17.96B), less than China Resources Double-Crane Pharmaceutical Co.,Ltd. (18.14B), less than Hybio Pharmaceutical Co., Ltd. (17.81B), greater than Fujian Cosunter Pharmaceutical Co., Ltd. (14.24B), greater than Beijing Aosaikang Pharmaceutical Co., Ltd. (14.00B), less than Shandong Buchang Pharmaceuticals Co., Ltd. (20.29B), greater than Zhejiang Jiuzhou Pharmaceutical Co., Ltd (13.77B), less than Apeloa Pharmaceutical Co.,Ltd (18.74B), greater than Guangdong Zhongsheng Pharmaceutical Co., Ltd. (15.92B), greater than Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (16.02B),

Build a custom stock screener for Walvax Biotechnology Co., Ltd. (300142.SZ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Walvax Biotechnology Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Walvax Biotechnology Co., Ltd. (300142.SZ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Walvax Biotechnology Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Walvax Biotechnology Co., Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Walvax Biotechnology Co., Ltd. (300142.SZ)?

What is the 3-year average Enterprise Value for Walvax Biotechnology Co., Ltd. (300142.SZ)?

What is the 5-year average Enterprise Value for Walvax Biotechnology Co., Ltd. (300142.SZ)?

How does the current Enterprise Value for Walvax Biotechnology Co., Ltd. (300142.SZ) compare to its historical average?